Cardiology Review - Issue 2/2012

63
Antiaggregating and anticoagulant therapy – basic principles

M. Penka

68
Oral antiplatelet therapy in patients with acute coronary syndrome

R. Štípal

72
Current guidelines for antiplatelet therapy in neurology

R. Herzig, M. Král

79
Anticoagulant therapy and atrial fibrillation

R. Lábrová, J. Špinar

88
New peroral antithrombotics in the prevention and treatment of tromboembolism

D. Karetová, J. Bultas

93
New antithrombotic drugs in the prophylaxis of postoperative venous thromboembolism

P. Kessler

97
Current possibilities of monitoring of antithrombotic therapy – new antithrombotic drugs

A. Buliková, J. Zavřelová, M. Matýšková

103
Where is a step in the current development of drugs that affect blood clotting?

J. Kvasnička


Reports from Foreign countries

109
Vorapaxar in clinical studies

J. Špinar, J. Vítovec, L. Špinarová

115
What is vernakalant and what is its place in clinical practice?

J. Murín, J. Vítovec

121
Eprosartan – dual blocker of AT1 receptors

J. Špinar, J. Vítovec, L. Špinarová


Case Report

126
Multiple administration of medication and circulatory failure for malignant ventricular arrhythmias and impairment of liver function

J. Vítovec, K. Židová


Case report - competitive

130
Heart Transplant Patient with Invasive Pulmonary Aspergillosis

P. Šajgalík, L. Špinarová, P. Hude, J. Krejčí, J. Godava, M. Tošková, Z. Ráčil, J. Vítovec, P. Němec


Login
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account